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ABSTRACT
Objective: The primary objective of this study was to probe the cytotoxic capacity of the labdane diterpenoids andrographolide (1), 
14-deoxyandrographolide (2), 14-deoxy-12-hydroxyandrographolide (3), and neoandrographolide (4) on mutant and wild-type immortalized cell 
lines.
Methods: Breast adenocarcinoma (MCF-7), colon carcinomas (HCT-116 and HT-29), small cell lung carcinoma (H69PR), human acute monocytic 
leukemia (THP-1), and wild-type primary normal human dermal fibroblasts - neonatal cells (HDFn) were incubated with 1-4, and the degree of 
cytotoxicity was analyzed by employing the in vitro PrestoBlue® cell viability assay. Working solutions of 1-4 were prepared in complete cell culture 
medium to a final non-toxic dimethyl sulfoxide concentration of 0.2%. The plates were incubated at 37°C with 5% CO2 in a 98% humidified incubator 
throughout the assay. Nonlinear regression and statistical analyses were done to extrapolate the half maximal inhibitory concentration 50% (IC50). 
One-way ANOVA (p<0.05) and multiple comparison, Tukey’s post hoc test (p<0.05), were used to compare different pairs of data sets. Results were 
considered statistically significant at p<0.05.
Results: The highest cytotoxicity index was exhibited by the H69PR and 1 trials which displayed the lowest IC50 value of 3.66 µg/mL, followed by 
HT-29 treated with 2, HCT-116 and 1 trials, and H69PR treated with 4 (IC50=3.81, 3.82, and 4.19 µg/mL, respectively). Only 1 and 4 were detrimental 
toward MCF-7, while 1, 3, and 4 were degenerative against H69PR. Tukey’s post hoc multiple comparison indicated no significant difference in the 
cytotoxicity of 1-4 on HCT-116 cells which afforded IC50 values ranging from 3.82 to 5.12 µg/mL. Evaluation of the two colon carcinoma cell lines 
showed that HCT-116 was categorically more susceptible to cellular damage caused by treatments with 1-4 than was HT-29. Cytotoxicity was not 
detected in THP-1 and HDFn cells (IC50>100 µg/mL).
Conclusion: Diterpenoids 1-4 isolated from the dichloromethane extract of the leaves of A. paniculata exhibited different cytotoxic activities against 
MCF-7, HCT-116, HT-29, and H69PR. All constituents had comparable action on HCT-116 cells but were not found to be cytotoxic to normal HDFn cells 
and mutant THP-1 cells.
Keywords: Andrographis paniculata, Andrographolide, 14-deoxyandrographolide, Neoandrographolide, Cytotoxicity.
INTRODUCTION
There has been an upsurge in cancer diagnosis and death worldwide. 
The root cause of this phenomena is linked to a longer lifespan and an 
incorporation of inappropriate activities such as smoking, physically 
inactive lifestyles, and unhealthy diets, especially in economically 
emerging nations. GLOBOCAN 2008 reported that there were 12.7 
million patients diagnosed with malignancies and 7.6 million mortalities 
associated with cancer which occurred in 2008. Statistical analyses 
stipulated that 56% of the pin-pointed patients and 64% of the deaths 
happened in developing countries [1]. Andrographis paniculata (Burm. f.) 
Nees, which belongs to the family Acanthaceae, has been found to have 
carcinopreventive and immunostimulatory constituents [2,3]. This herb, 
which is found locally in Taiwan, Mainland China, and India, leaves an 
acrimonious taste to the palate. It is used in traditional medicine for liver 
disorders, bowel discomfort of children or colic, and viral or bacterial 
upper respiratory tract infections [4-6]. Chinese medicine postulated 
that the aerial part of A. paniculata has the ability to decrease body 
temperature, reduce inflammation, and relieve aches. Concoctions of this 
plant have been linked with physiological detoxification or purging [7-9].
Steroids, alkaloids, flavonoids, triterpenoids, tannins, saponins, 
quinone, coumarin, protein, sugar, and gum were the constituents 
established to be present in A. paniculata [10]. Diterpenoids, flavonoids, 
and polyphenols have been found to be the chemotherapeutic agents 
of A. paniculata [11,12]. Pharmacokinetic interaction experiments 
propose that A. paniculata could cause the inhibition of UDP-
glucuronosyltransferase in drug metabolism [13]. The flavonoids 
isolated from the ethyl acetate fraction derived from ethanolic or 
methanolic extraction were reported to contain 5-hydroxy-7,8-
dimethoxyflavone, 5-hydroxy-7,8,2’,5’-tetramethoxyflavone, 5-hydroxy-
7,8,2’,3’-tetramethoxyflavone, 5-hydroxy-7,8,2’-trimethoxyflavone, 
7-O-methylwogonin, and 2’-methyl ether [14-16]. The ethyl acetate 
fraction of A. paniculata in conjunction with doxorubicin considerably 
(p<0.05) escalated programed cell death in mice fibrosarcoma cells and 
diminished vascular endothelial growth factor production (p<0.05) [17]. 
The primary diterpene of A. paniculata was stated to be rographolide 
and has been chronicled to constitute 4%, 0.8~1.2%, and 0.5~6% in 
dried whole plant, stem, and leaf preparations, respectively [18-20]. 
Other prominent labdane diterpenoids were deoxyandrographolide, 
neoandrographolide, 14-deoxy-11,12-didehydroandrographide, and 
isoandrographolide [15,17].
Our previous investigation recounted the isolation of 14-deoxy-12-
hydroxyandrographolide, 14-deoxyandrographolide, and 14-deoxy-
11,12-dihydroandrographolide from the leaves of A. paniculata [21]. 
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i12.19194
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Recently, we reported the isolation of andrographolide, 
14-deoxyandrographolide, 14-deoxy-12-hydroxyandrographolide, 
β-sitosterol, stigmasterol, and chlorophyll a from the leaves; β-sitosterol, 
stigmasterol, 5,2’-dihydroxy-7,8-dimethoxyflavone, long chain trans-
cinnamate esters, and β-sitosteryl fatty acid esters from the roots; 
β-sitosterol, monogalactosyl diacylglycerols, lupeol, and triacylglycerols 
from the pods; and 14-deoxyandrographolide from the stems of 
A. paniculata [22]. We also reported the isolation of squalene, polyprenol, 
lutein, chlorophyll a, and a mixture of β-sitosterol and stigmasterol 
in a 3:1 ratio from the stems; and α-amyrin acetate, triacylglycerols, 
and a mixture of lupeol, α-amyrin, and β-amyrin in about 2:2:1 ratio 
from the leaves of A. paniculata [23]. Our most recent research from 
the dichloromethane extracts of the leaves of A. paniculata led to the 
isolation of neoandrographolide, 1,5-dimethyl-1,5-cyclooctadiene and 
2-hydroxyethyl benzoate, and squalene from the leaves, while the stems 
yielded 1,5-dimethyl-1,5-cyclooctadiene [24].
In this work, the cytotoxic capabilities of andrographolide (1), 
14-deoxyandrographolide (2), 14-deoxy-12-hydroxyandrographolide 
(3), and neoandrographolide (4) against the immortalized human 
cell lines, breast adenocarcinoma (MCF-7), colon cancer (HCT-116 
and HT-29), small cell lung carcinoma (H69PR), and acute monocytic 
leukemia (THP-1) were established. To the best of our knowledge, 
this is the first reported study using this methodology of cytotoxic 
and anti-proliferative analyses on 1-4 from A. paniculata against the 
aforementioned human cancer cells as shown in following Fig. 1.
METHODS
Sample collection
The A. paniculata (Burm.f.) Nees leaves were grown and harvested in 
Abucay, Bataan, on September 2015. The sample was authenticated at 
the botany division of the Philippine National Museum.
Isolation
The labdane diterpenoids 1-3 [22] and 4 [23] were isolated from the 
leaves of A. paniculata. The isolation procedures were previously 
reported [22,23].
Preparation of compounds
Compounds 1-4 from A. paniculata were reconstituted in dimethyl 
sulfoxide (DMSO) to formulate an initial solution of 4 mg/mL. 
Dilutions were made from the stock solution using 0.2% DMSO and the 
appropriate cell culture medium.
Maintenance and preparation of cells
The dichloromethane (CH2Cl2) extracts of A. paniculata were analyzed for 
their bioactivity on the following human cell lines purchased from ATCC, 
Manassas, Virginia, U.S.A.): Breast cancer (MCF-7), colon cancer (HCT-116 
and HT- 29), small cell lung carcinoma (H69PR), human acute monocytic 
leukemia (THP-1); and a primary culture of normal human dermal 
fibroblast and neonatal (HDFn) (ThermoFisher Scientific, Gibco®, USA) 
which were stored at the Cell and Tissue Culture Laboratory, Molecular 
Science Unit, Center for Natural Science, and Environmental Research 
at De La Salle University. Standard protocols were strictly adhered to 
throughout the analyses [25]. Complete growth medium comprised of 
Dulbecco’s Modified Eagle Medium (DMEM, ThermoFisher Scientific 
Gibco®, USA), having 10% fetal bovine serum (FBS, ThermoFisher 
Scientific, Gibco®, USA), and 1x antibiotic-antimycotic (ThermoFisher 
Scientific, Gibco®, USA) was used in the plate cultures. To maintain the 
environment of the cell cultures, the plates were placed in a humidified 
incubator at 37°C with 5% CO2 in98% humidity. The monolayer adherent 
cells, after attainment of 80% confluence, were rinsed with phosphate-
buffered saline (PBS, pH 7.4, ThermoFisher Scientific, Gibco®, USA), 
trypsinized with 0.05% Trypsin-EDTA (ThermoFisher Scientific, Gibco®, 
USA) and reconstituted with freshly prepared media. Cells were counted 
following a standard trypan blue exclusion method (0.4% Trypan Blue 
Solution from ThermoFisher Scientific, Gibco®, USA). Seeding of the 96-
well microtiter plate (FalconTM, USA) in 100µL portions was calculated to 
have 1 × 104 cells per well. Cell viability was found to be greatly affected 
by toxic agents at lower starting cell density or cell count, whereas higher 
optical densities of cells readily bound and rendered unavailable the added 
agents [26]. Due to these reported incidences, the researchers chose this 
level of cell density to avoid any perturbations caused by unsuitable OD. 
To accomplish optimum cell attachment, additional incubation of the 
plates in a 37°C with 5% CO2 in a 98% humidified environment was done 
overnight. The bioassays, as defined in the subsequent section, will be 
undertaken on the processed plates.
Cell viability assay
The degree of cytotoxicity of the A. paniculata compounds on 
the immortalized cell lines was established using PrestoBlue® 
(ThermoFisher Scientific, Molecular Probes®, in vitro gen, USA) 
for cell viability analyses. The basis of the bioassay hinges on the 
measurement of the quantity of mitochondrial reductase in intact cells 
which metabolically alters resazurin dye (blue and nonfluorescent) to 
resorufin (red and highly fluorescent). The reaction is proportionate 
to the amount of metabolically viable cells which is quantified 
spectrophotometrically at absorbance measurements of 570 nm. 
Aliquots of 100 µL of filter purified 1-4 were first applied to the cells 
in the microtiter plate. Subsequent two-fold serial dilutions of 50, 25, 
12.5, 6.25, 3.12, 1.56, 0.78, and 0.39 µg/mL were done after the first 
treatment on each trial. The plates were then subjected to an incubation 
period of 4 days at 37°C in 5% CO2 and 98% humidity. PrestoBlue® 
(twenty microliters) was administered to each well. Another incubation 
period for 1 hr at 37°C in 5% CO2 and 98% humidity was employed 
to the monolayers. Negative controls were the wells which were not 
treated with any of the samples, and the positive control was the wells 
treated with the cytotoxic agent ZeocinTM (ThermoFisher Scientific, 
Gibco®, USA). Spectrophotometric analyses were performed using a 
BioTek ELx800 Absorbance Microplate Reader (BioTek® Instruments, 
Inc., USA) at 570 nm and normalized to 600 nm values (reference 
wavelength). Cell viability for each sample concentration was evaluated 
following the equation below.
−
−
Cell viability %= 
(Absorbance of treated sample absorbance of blank) ×100
(Absorbance of negativecontrol absorbance of blank)
Fig. 1: Chemical structures of 1-4
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GraphPad Prism 7.01 (GraphPad Software, Inc.) was employed to 
compute for nonlinear regression and the half maximal inhibitory 
concentration 50% (IC50) (the concentration of the constituent which 
caused a 50% decline in cell viability). The extent of cytotoxicity of 
1-4 was stated as IC50 values. Every trial was executed in triplicate 
and the data displayed as mean±standard deviation error. Evaluation 
of the variances in the best-fit parameters (half maximal inhibitory 
concentration) between treatments and regularities among dose-
response curve fits was verified using the extra sum-of-squares F-test 
or Brown–Forsythe test. Significant variances among data sets were 
ascertained through one-way ANOVA (p<0.05) followed by Tukey’s post 
hoc test (p<0.05) for multiple comparisons. Results were deliberated to 
be statistically significant at p<0.05.
RESULTS AND DISCUSSION
The cytotoxicity of andrographolide (1), 14-deoxyandrographolide (2), 
14-deoxy-12-hydroxyandrographolide (3), and neoandrographolide (4) 
were investigated on MCF-7, HT-29, HCT-116, H69PR, THP-1, and HDFn. 
Analyses of the cytotoxicity of 1-4 against THP-1 resulted to IC50 values 
exceeding 100 µg/mL, suggesting absence of cytotoxic activities, and 
were excluded from further statistical analysis. Zeocin, an intercalating 
agent, was used as the positive control in all the trials. An illustration 
of the percent cell viability as a function of the logarithmic function of 
the concentrations used is presented in Figs. 2 and 3. The characteristic 
inhibitory dose response, which is a sigmoidal curve or function, was 
found in generally most of the charts. Plots comparing the cytotoxic 
properties of 1-4 on the viability of each specific cell line are found in 
Fig. 2. The effects of each individual constituent on all the cell lines are 
shown in Fig. 3. IC50 values of the isolates and the positive control are 
synopsized in Table 1.
Within the MCF-7 subset, 1 demonstrated considerable activity toward 
breast adenocarcinoma as exhibited by the IC50 value of 4.21 µg/mL, 
followed by the activity of 4 with an IC50 value of 6.63 µg/mL. No 
cytotoxicity was displayed by 2 and 3 since the IC50 values were greater 
than 100 µg/mL. No significant differences, as found in Tukey’s post hoc 
multiple comparison, were found between 1 versus 4, 1 versus Zeocin, 
and 4 versus Zeocin (p>0.05), while all the other paired treatments 
were found to be significantly different (p<0.0001).
Compounds 1-4 exhibited marked degradative properties on HCT-116 
with 1 being the most damaging at an IC50 value of 3.82 µg/mL and 4, 
3, and 2 following suit with IC50values of 4.43, 4.82, and 5.12 µg/mL, 
respectively. Post hoc analysis exhibited no significant differences 
between the paired treatments (p>0.05).
HT-29 was most vulnerable to 2 with an IC50 value of 3.81 µg/mL. 
Impediment of the viability of HT-29 cells on 1, 3, and 4 was only 
established at elevated concentrations, as evidenced by the IC50 values 
of 69.19 µg/mL for 3, 83.03 µg/mL for 4 and >100 µg/mL for 1. The 
IC50 data of the subsets 1 versus 2, 2 versus 3, 2 versus 4, 1 versus 
zeocin, 3 versus Zeocin, and 4 versus Zeocin were statistically different 
(p<0.0001), while the remaining paired treatments were similar 
(p>0.05).
Diterpenoid 1 gave the highest efficacy toward H69PR with a half 
maximal inhibitory concentration of 3.66 µg/mL, which was followed 
by 4 and 3 which gave IC50 values of 4.19 and 4.86 µg/mL, respectively. 
Compound 2 was non-cytotoxic and was only able to decrease cell 
viability by 50% at IC50> 100 µg/mL. Statistical paired treatments 
Table 1: Cytotoxic activities (IC50) of 1-4 and Zeocin against 
MCF-7, HCT-116, HT-29, H69PR, and HDFn
Compound IC50* (µg/mL)
MCF-7 HCT-116 HT-29 H69PR HDFn
1 4.21 3.82 >100 3.66 >100
2 >100 5.12 3.81 >100 >100
3 >100 4.82 69.19 4.86 >100
4 6.63 4.43 83.03 4.19 >100
Zeocin 3.70 4.25 3.50 4.82 3.76
*IC50 values were extrapolated from dose-response curves calculated 
from nonlinear regression analysis using GraphPad Prism 7.01 (GraphPad 
Software, Inc.) and one-way ANOVA was the treatment employed for each 
cell line to evaluate the significant variances among the data groups. The 
statistical analyses are as follows: MCF-7, F (4, 35)=11.31, p<0.0001; HCT-116, 
F (4, 35)=0.07427, p=0.9895; HT-29, F (4, 35)=5.661, p=0.0013; H69PR, 
F (4, 35)=1.38, p=0.2609; HDFn, F (4, 35)=15.62, p<0.0001. IC50: Inhibitory 
concentration 50%, HDFn: Human dermal fibroblasts - neonatal cells
Fig. 2: Dose-response curves showing the cytotoxic activities of 1-4 and Zeocin on the cell viability of MCF-7, HCT-116, HT-29, and H69PR: 
Each plot displays the effect of 1-4 and Zeocin against each cell line. Data are shown as mean±standard deviation error. GraphPad Prism 
7.01 was used to perform extra sum-of-squares F-test to (a) evaluate the significance of the best-fit-parameter (half maximal inhibitory 
concentration) among different treatments and to (b) determine the differences among the dose-response curve fits. The results are: MCF-
7, (a) F (4, 110)=464.7, p<0.0001; (b) F (4, 35)=3.926, p=0.0098, HCT-116; (a) F (4, 110)=2.861, p=0.0267; (b) F (4, 35)=0.604, p=0.6623; 
HT-29, (a) F (4, 110)=155,2, p<0.0001; (b) F (4, 35)=1.364, p=0.2662, H69PR; (a) F (4, 110)=20.37, p<0.0001; (b) F (4, 35)=6.688, 
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between pairs displayed that 1 versus 3, 1 versus 4, 3 versus 4, 1 versus 
Zeocin, 3 versus Zeocin, and 4 versus Zeocin were not statistically 
different (p>0.05), while the other treatments were distinctly diverse 
(p<0.0001).
All the isolates were established not to be cytotoxic to wild-type HDFn, 
with IC50 values substantially surpassing concentrations of 100 µg/
mL. Compounds 1 versus 4, 3 versus 4, 3 versus Zeocin, and 4 versus 
Zeocin were found to be significantly disparate (p<0.006). Zeocin a 
known cytotoxic agent gave IC50 values of 3.70, 4.25, 3.50, 4.82, and 
3.76 µg/mL for MCF-7, HCT-116, HT-29, H69PR, and HDFn, respectively, 
and multiple comparisons showed no significant difference among the 
trials (p>0.05). Post-hoc comparison of the dose-response curve fits for 
most of the cell line treatments exhibited significant differences, with 
the exception of the analyses of HCT-116 trials with 1-4 which were not 
statistically different (p>0.05) (Figs. 1 and 2).
Assessment of the effectiveness of 1-4 on the four immortalized cancer 
cell lines revealed that the integrity of HCT-116 cells consistently 
decreased in all the trials, and the action of cytotoxicity was analogous 
to the positive control Zeocin. For the most part, H69PR cells also 
followed this trend of degeneration with the exception of 2, and in 
HT-29, high half maximal inhibitory concentrations were acquired 
for most of the trials, with the exception of 1. On the other hand, only 
1 and 4 were cytotoxic to MCF-7. With regard to the efficacy of each 
compound, 1 was most effective toward H69PR, HCT-116, and MCF-7, 
with IC50 values of 3.66, 3.82, and 4.21 µg/mL, respectively. Labdane 
diterpenoid 2 was most effectual against HCT-116 and HT-29 with 
IC50 values of 5.12 and 3.81 µg/mL, correspondingly. Compound 
3 was also found to be a degenerative agent toward HCT-116 and 
HT-29; however, HT-29 was only damaged at a higher concentration 
of 69.19 µg/mL. In addition, 3 was detrimental to H69PR at an IC50 
value of 4.86 µg/mL. Diterpenoid glucoside 4 exhibited highest 
efficacy toward H69PR (IC50 = 4.19 µg/mL), followed by the cell lines 
HCT-116 (IC50 = 4.43 µg/mL) and MCF-7 (IC50 = 6.63 µg/mL), and was 
non-cytotoxic to HT-29 (IC50 = 83.03 µg/mL). Wild-type HDFn gave half 
maximal inhibitory concentrations of greater than 100 µg/mL in all of 
the trials.
The stipulated active cytotoxic limits of natural products are 20 µg/mL 
or less for crude extracts and 4 µg/mL or less for pure compounds [27], 
and constituents that have been purified which exhibit promising 
cytotoxicity levels are possible proponents for drug development [28]. 
The findings in this work disclosed that 1-4 from A. paniculata can 
be candidates for chemotherapeutic drugs or used as a corollary for 
medical protocols in dealing with the management of human colon and 
colorectal cancer, human breast adenocarcinoma, and human small cell 
lung carcinoma.
This research displayed that the cytotoxicity of 1-4 was reliant on the 
particular immortalized cancer cell line used. Comparison of the two 
colon carcinomas showed that HCT-116 was more responsive to all the 
compounds, especially to 1, and HT-29 was highly deteriorated by 2 and 
marginally affected by 3 and 4. This disparity can be explained by tumor 
heterogeneity which can exhibit variance in drug-related response due 
to the modification and differences in HCT-116 and HT-29 expression 
profiles [29]. Transformations on the gene sequence such as in the 
mutant form of the p53 gene in HT-29 has made this type of colorectal 
cancer more resilient to the cytotoxic action of doxorubicin than the 
HCT-116 cell line, carrying a normal-type p53 gene [30].
Literature search on the cytotoxic and chemotherapeutic activity of the 
diterpenes in A. paniculata has been conducted; however, to the best of 
our knowledge, no reported activities on1-4 using these cell lines and 
these parameters have been cited.
Andrographolide’s anticancer pharmacognosy has been linked to its 
ability to subdue tumor growth, instigation of apoptosis, prevention of 
angiogenesis, and the hindrance of the neoplasm’s anti-transformative 
capacity [31]. Andrographolide (1) was found to promote DNA 
fragmentation at concentrations of 0.35 mM, 0.70 mM, and 1.40 mM. 
The accelerated accumulation of apoptotic cells was observed when 
TD-47 human breast cancer cells were incubated with andrographolide 
for 24, 48, and 72 hrs. The onset of apoptosis in TD-47 and human breast 
cancer cell line was determined to be subject to the length of time of 
the treatment and the concentration of the constituent. The mechanism 
of apoptosis was proposed to be due to the upregulation of p53, bax, 
and caspase-3 and down-regulation of bcl-2 as analyzed through 
immunohistochemical analysis [32]. Using a dual-luciferase reporter 
assay, it was found that HIF-1 in T47D cells at EC50 of 1.03×10−7mol/L 
led to the decrease of vascular endothelial growth factor (VEGF) [33]. 
The decline of the proliferation of the mutant cells from human breasts, 
MDA-MB-231, was attributed to the rise in reactive oxygen species 
which occurs concurrently with the loss in mitochondrial membrane 
Fig. 3: Dose-response curves showing the cytotoxic activities of 1-4 and Zeocin on the cell viability of MCF-7, HCT-116, HT-29, H69PR, 
and human dermal fibroblasts - neonatal cells: Each plot displays the effect of 1-4 and Zeocin against each cell line. Data are shown as 
mean±standard deviation error. GraphPad Prism 7.01 was used to perform extra sum-of-squares F-test to (a) evaluate the significance of 
the best-fit-parameter (half maximal inhibitory concentration) among different treatments, and to (b) determine the differences among 
the dose-response curve fits. The results are: 1, (a) F (4, 110)=92.64, p<0.0001; (b) F (4, 35)=3.221, p=0.0237, 2; (a) F (4, 104)=409.6, 
p<0.0001; (b) F (4, 33)=6.767, p=0.0004, 3; (a) F (4, 110)=164.5, p<0.0001; (b) F (4, 35)=8.636, p<0.0001, 4; (a) F (4, 110)=125.4, 
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potential and externalization of phosphatidylserine [34]. Compound 
1 has been implicated in the stimulation of heme oxygenase-1 (HO-1) 
expression which has been found to moderately contribute to the 
inhibition of TPA-induced matrix metalloproteinase-9 (MMP-9) and 
MCF-7 cells motility [35]. A comparable inhibitory influence of 1 on 
HT-29 was observed by the encumbrance of the migration of colon 
carcinoma through the inhibition of MMP-2 [31]. The combination 
of 1 with cisplatin (CDDP) induced a synergistic inhibition on the 
growth of human colorectal carcinoma lovo cells and was found to 
initiate apoptosis in vitro [36]. Andrographolide normalized VEGF and 
TGF-β1 levels and constrained protein kinase C in H3255 cells which 
contributed to a decrease in the proliferation of lung cancer cells in a 
concentration-dependent assay [37]. In A549 cells, 1 was established 
to facilitate continued downregulation of phosphatidylinositol 3-kinase 
(PI3K)/Akt signal which was involved in the gene expression of MMPs 
in reaction to activator protein-1 (AP-1) [38]. Therefore, previously 
reported signaling pathways and mechanisms involved verifies our 
results that 1 has notable cytotoxicity at an IC50 value 4.21 µg/mL and can 
be considered as a bioactive agent against breast adenocarcinoma cell 
line MCF-7 with low cytotoxicity to wild-type HDFn (IC50> 100 µg/mL).
The chemotherapeutic pathways mediated by andrographolide 
treatment involve the inhibition of Janus tyrosine kinases–signal 
transducers and activators of transcription, PI3K, and NF-κB signaling 
pathways, suppression of heat shock protein 90, cyclins and cyclin-
dependent kinases, metalloproteinase and growth factors, and the 
induction of proteins p53 and p21, leading to the disablement of 
aberrant cell viability, tumor - cell invasion/migration, and growth in 
the vascular network [39].
After incubation with 14-deoxyandrographolide (2), amplified 
microsomal Ca-ATPase action due to the instigation of the NO/cGMP 
conduit was observed. This resulted in the inhibition of a death-
inducing signaling complex (TNFRSF1A–ARTS-1–NUCB2) in cellular 
compartments, rendering the hepatocytes incapable of TNF-α-
induced cell death[40]. An earlier research has revealed that 2 
acts as an immunomodulatory and anti-atherosclerotic agent [31]. 
Chemotherapeutic and anti-cancer properties of specific agents possess 
inherent selective growth inhibition or cytotoxic properties [41].
On the other hand, 14-deoxy-12-hydroxyandrographolide (3) was 
reported to be cytotoxic to human lung carcinoma (A549) with an IC50 
value of 20 μg/mL and manifested minimal antimicrobial response [21].
Neoandrographolide (4) was found to act as a chemosensitizer in 
S-Jurkat and X chromosome-linked deterrence of apoptosis protein 
(XIAP)-overexpressing Jurkat cells [42]. Andrographolide, 14-deoxy- 
andrographolide, and neoandrographolide were isolated from 
chloroform and methanolic extracts of A. paniculata. Among these 
compounds, 4 possessed cytotoxic activity against cancer cell lines Hep 
G2 and HCT-116 as assessed by the MTT Assay. Evidence of apoptosis or 
necrosis was analyzed using DAPI, and acridine orange displayed DNA 
fragmentations which confirmed that cell death occurred due to the 
apoptotic pathway [43].
The structure-activity relationships of synthesized 1 analogs as novel 
cytotoxic agents disclosed that the intact α-alkylidene γ-butyrolactone 
moiety of 1, the D12(13) double bond, the C-14 hydroxyl or its ester 
moiety, and the D8(17) double bond or epoxy moiety were responsible 
for the degenerative activities induced by 1 and its derivatives [44]. The 
presence of these functionalities within 1-4 could be the explanation of 
the cytotoxic action observed in the MCF-7, HCT-116, HT-29, and H69PR 
immortalized cell lines.
CONCLUSION
The labdane diterpenoids and andrographolide (1), 
14-deoxyandrographolide (2), 14-deoxy-12-hydroxyandrographolide 
(3), and neoandrographolide(4) isolated from the dichloromethane 
extract of the leaves of A. paniculata exhibited different cytotoxic 
activities against MCF-7, HCT-116, HT-29, and H69PR, respectively. 
The comparison of the cytotoxic activity of 1-4 was highest for H69PR 
with an IC50 value of 3.66 µg/mL for 1, followed by HT-29 with an IC50 
value of 3.81 µg/mL for 2, HCT-116 with an IC50 value of 3.82 µg/mL 
for 1, H69PR with an IC50 value of 4.19 µg/mL for 4, and MCF-7 with 
an IC50 value of 4.21 µg/mL for 1. Diterpenoid 3 was found to be most 
degenerative to HCT-116 with an IC50 value of 4.82 µg/mL. Isolates 
1-4 displayed substantial antiproliferative action on the human colon 
carcinoma immortalized cell line, HCT-116. Post hoc multiple analyses 
exhibited no significant difference in the dose-response curve fits of the 
cytotoxicity of 1-4 on HCT-116 cells with IC50 values ranging from 3.82 
to 5.12 µg/mL. All compounds were not found to be cytotoxic to normal 
HDFn cells and mutant THP-1 cells with IC50 values of>100 µg/mL.
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